Kv1.5 Inhibitors for Treatment of Atrial Fibrillation: A Tradeoff between Selectivity and Non-selectivity

E-ISSN： 1873-4294|16|16|1843-1854

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.16, 2016-07, pp. : 1843-1854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kv1.5 Blockers for the Treatment of Atrial Fibrillation: Approaches to Optimization of Potency and Selectivity and Translation to In Vivo Pharmacology

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 436-451

Bentham Science Publishers

Access to resources Recommend Favorite

I_Kur/Kv1.5 channel blockers for the treatment of atrial fibrillation

By Tamargo Juan Caballero Ricardo Gómez Ricardo Delpón Eva

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 399-416

Informa Healthcare

Access to resources Recommend Favorite

Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias

By Brendel Joachim Peukert Stefan

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1589-1598

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity

By Blomström-Lundqvist Carina Blomström Per

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite

Recent developments of cathepsin inhibitors and their selectivity

By Kang Kooil Kim Woomi

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 3, 2002-03 ,pp. : 419-432

Informa Healthcare

Access to resources Recommend Favorite